Walgreens Boots Alliance, Inc. (WBA) Enterprise Value (EV): $18.60B
The enterprise value (EV) for Walgreens Boots Alliance, Inc. (WBA) is $18.60B as of Saturday, June 13, 2026.
WBA Enterprise Value (EV) Metrics
ENTERPRISE VALUE (EV)
$18.60B
WBA Competitors' Enterprise Value (EV)
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Walgreens Boots Alliance, Inc. (WBA) | $10.37B | $18.60B |
| Baxter International Inc. (BAX) | $10.77B | $17.84B |
| Charles River Laboratories International, Inc. (CRL) | $9.03B | $12.95B |
| Tempus AI, Inc. (TEM) | $8.35B | $10.50B |
| Align Technology, Inc. (ALGN) | $12.52B | $10.36B |
| Bio-Rad Laboratories, Inc. (BIO) | $7.73B | $9.26B |
| The Cooper Companies, Inc. (COO) | $13.24B | $16.66B |
| Solventum Corporation (SOLV) | $13.66B | $17.95B |
| Hims & Hers Health, Inc. (HIMS) | $5.98B | $8.34B |
| Hologic, Inc. (HOLX) | $16.97B | $15.94B |
Enterprise Value Calculation
Market Cap
$10.37B
Total Debt
$9.55B
Cash
$1.32B
Enterprise Value
$18.60B
EV-Based Valuation Multiples
Why use EV instead of Market Cap?
- EV accounts for debt - an acquirer must pay or assume it
- EV deducts cash - the acquirer effectively receives it
- EV enables fair comparison of companies with different capital structures
- EV-based ratios (EV/EBITDA, EV/Sales) are capital structure neutral
Walgreens Boots Alliance, Inc. Enterprise Value (EV) Formula & Definition
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Walgreens Boots Alliance, Inc. Enterprise Value (EV) FAQ
- What is the enterprise value (EV) for Walgreens Boots Alliance, Inc. (WBA)?
- The enterprise value (EV) for WBA stock is $18.60B.
Related Metrics
About Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc., established in 1901 and based in Deerfield, Illinois, operates as a leading global retailer focused on pharmacy, health, and beauty products. Its business activities are organized into two primary divisions: the United States and International. In the United States, the company dispenses prescription drugs and offers a diverse selection of retail goods. This includes items for health, wellness, beauty, and personal care, alongside general merchandise and consumable products, all available through its extensive network of retail drugstores. The U.S. segment also provides specialized central pharmacy services and mail delivery options for prescriptions. As of August 31, 2021, this division managed 8,965 retail outlets under the Walgreens and Duane Reade banners, complemented by five specialty pharmacies. The International segment focuses on the sale of prescription medications, health and wellness items, beauty products, personal care essentials, and other consumer goods. These are sold through its pharmacy-centric health and beauty retail locations, optical practices, its online platform boots.com, and an integrated mobile application. Additionally, this segment engages in pharmaceutical wholesale and distribution operations within Germany. By August 31, 2021, the international portfolio included 4,031 retail stores operating under brands such as Boots, Benavides, and Ahumada, located across countries including the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. It also oversaw 548 optical practices, with 160 of these operating as franchises.
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Timothy C. Wentworth